Sym­po­sium Spon­sored by the National Cancer Insti­tute to take place at NSTI’s Nanotech2008 in at the Hynes Con­ven­tion Center, Boston, MA

North­eastern Uni­ver­sity pro­fes­sors Vladimir Torchilin and Man­soor Amiji are co-​​chairing a sym­po­sium at Nan­otech 2008 con­fer­ence, enti­tled “Nan­otech­nology for Cancer Pre­ven­tion, Diag­nosis and Treat­ment.” Pre­sented by the Nano Sci­ence and Tech­nology Insti­tute (NSTI) in col­lab­o­ra­tion with the National Cancer Insti­tute (NCI), the one-​​day sym­po­sium on June 4th will fea­ture ses­sions by promi­nent mem­bers of the nan­otech­nology and cancer research com­mu­nity rep­re­senting industry, health­care, gov­ern­ment and academia.

This sym­po­sium will address the poten­tial ways in which nan­otech­nology can address the chal­lenges asso­ci­ated with timely cancer diag­nosis, tumor tar­geting and local­ized delivery. Each area presents its respec­tive obsta­cles that sci­en­tist are working to over­come, including accu­rate detec­tion and diag­nosis at the ear­liest stage and local­ized drug delivery methods, while saving the normal tissue from the exces­sive burden of toxicity.

During the Sym­po­sium, the co-​​chairs will dis­cuss their respec­tive research areas:

  • Vladimir Torchilin, Distinguished Professor of Pharmaceutical Sciences at Northeastern’s Bouve College of Health Sciences will present “Multifunctional Nanocarriers for Cancer Therapy” on Wednesday, June 4th.
  • A paper, co-authored by Torchilin and his team, titled “Micellar Form of Novel Poorly Soluble Pro-Apoptitic Agent, N-([(2-hydroxy-5-nitrophenyl) amino] carbonothioyl}-3, 5-dimethylbenzamide (PIT) for Effective Targeting to Solid Tumors” will be part of a session focusing on drug delivery and therapeutics, on Tuesday, June 3rd
  • Mansoor Amiji, Professor and Associate Department Chairman of the Pharmaceutical Sciences Department in Northeastern’s Bouve College of Health Sciences, and Co-Director of Nanomedicine Education and Research Consortium (NERC) at Northeastern, will present a paper he co-authored with his team, titled “Epidermal Growth Factor Receptor-Targeted Engineered Gelatin Nanovectors for Gene Delivery in Pancreatic Cancer Cells” on Monday, June 2nd and another titled “Gene Delivery and Transfection Studies with Lipopolyplexes in Human Endothelial and Smooth Muscle Cells.” The session on drug and gene delivery systems will take place on Thursday, June 5th.

The Sym­po­sium will run par­allel with the Nan­otech 2008 and the Bio­Nano 2008 con­fer­ences, pro­viding a unique, mul­ti­dis­ci­pli­nary envi­ron­ment directed towards addressing the chal­lenges of nan­otech­nology appli­ca­tions in biology and medicine.

For more infor­ma­tion on the Sym­po­sium and the NSTI Nan­otech 2008 conference,visit http://​www​.nsti​.org/​N​a​n​o​t​e​c​h​2​0​0​8​/​s​y​m​p​o​s​i​a​/​C​a​n​c​e​r​_​D​i​a​g​n​o​s​t​i​c​s​_​I​m​a​g​i​n​g​_​T​r​e​a​t​m​e​n​t​.​h​tml and con­tact Renata Nyul at 617–373-7424 or at r.​nyul@​neu.​edu.

About North­eastern

Founded in 1898, North­eastern Uni­ver­sity is a pri­vate research uni­ver­sity located in the heart of Boston. North­eastern is a leader in inter­dis­ci­pli­nary research, urban engage­ment, and the inte­gra­tion of class­room learning with real-​​world expe­ri­ence. The university’s dis­tinc­tive coop­er­a­tive edu­ca­tion pro­gram, where stu­dents alter­nate semes­ters of full-​​time study with semes­ters of paid work in fields rel­e­vant to their pro­fes­sional inter­ests and major, is one of the largest and most inno­v­a­tive in the world. The Uni­ver­sity offers a com­pre­hen­sive range of under­grad­uate and grad­uate pro­grams leading to degrees through the doc­torate in six under­grad­uate col­leges, eight grad­uate schools, and two part-​​time divi­sions. For more infor­ma­tion, please visit www​.north​eastern​.edu.